Las Vegas, NV — Sunrise Hospital and Medical Center is one of the first to offer Blue-Light Cystoscopy with Cysview® (hexaminolevulinate hydrochloride), an optical imaging solution for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer to the public in Southern Nevada. Cysview, which is made by Photocure Inc., is the only FDA-approved imaging agent for use with Blue-Light Cystoscopy.

Sunrise and certain physicians were selected because of the continuous advances that we offer the community and treatment options provided within Southern Nevada. Dr. Jayram Krishnan and Dr. Scott Slavis, of Cleveland Clinic Urology, have been the first in working on these case studies because of their specialized area with technology advancements and bladder cancer.

In Blue-Light Cystoscopy with Cysview, the imaging solution (Cysview) is delivered into the bladder about an hour prior to the cystoscopy and is absorbed by cancerous tissue. Using the KARL STORZ Photodynamic Diagnostic (PDD) system, the doctor inserts a long thin tube into the bladder. The doctor will use the white-light that is the standard procedure for this detection and then switch to the blue-light mode. Because of the Blue-Light Cysview, this allows hard-to-see tumors that are present to become more visible, standing out against normal bladder tissue and making it easier for the doctor to identify and remove.

“Since bladder cancer is difficult to detect and carries the highest lifetime treatment costs per patient of all cancers, this means our patients who qualify for this will have a better chance in their quality of treatment and don't have to leave the state for the latest care. It means that they are receiving the best care here, at home,” said Todd P. Sklamberg, Sunrise Hospital Chief Executive Officer. “This is in part in keeping with our commitment to bringing innovative new treatment approaches to patients.”

Bladder cancer is the sixth most commonly diagnosed cancer in the United States. The American Cancer Society estimates that 72,570 new cases of bladder cancer are diagnosed in the U.S. each year. Bladder cancer can recur within 50 to 80 percent of patients.

Sunrise Hospital is the leader in patient care and innovative medical and surgical treatments,” said Dr. Krishnan after his fifth surgery involving this protocol. “Patients don't need to go out of town to get the most advanced care. We're currently the only public facility in Southern Nevada to offer this type of surgery.”

About Sunrise Hospital & Medical Center

As Nevada's largest acute care facility and Level II Trauma Center, Sunrise Hospital & Medical Center offers high quality, patient-centered healthcare to the residents of Southern Nevada, its surrounding region, and the millions of visitors that come to Las Vegas. As a 16-time Consumer Choice award-winning hospital and two-time “Best Hospital in Las Vegas,” Sunrise Hospital & Medical Center is the region's healthcare leader. The Heart Center at Sunrise offers the most advanced cardiac care and features an Accredited Chest Pain Center. The Nevada Neurosciences Institute — the region's most comprehensive Joint Commission Certified Primary Stroke Center — provides world-class care for stroke, epilepsy, multiple sclerosis, and other neurological conditions. The Breast Center at Sunrise Hospital is the only Accredited Breast Center in Southern Nevada. Located on the same campus is Sunrise Children's Hospital, Nevada's largest, most comprehensive children's hospital. For more information on Sunrise Hospital & Medical Center, visit, follow on Twitter and

Need to find a physician or get answers to your health questions? Call (702) 233-5454.

About Cysview® (hexaminolevulinate hydrochloride) for Intravesical Solution

Cysview is indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy. Cysview is used with the Karl Storz D-Light C Photodynamic Diagnostic (PDD) system to perform cystoscopy with the blue light setting (Mode 2) as an adjunct to the white light setting (Mode 1). Cysview is not for repetitive use and is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer.

tags: fwd